Former GSK Site in Pennsylvania Gets Revamped into Life Sciences Hub

In June 2019, MLP Ventures’ The Discovery Labs announced renovation plans for GlaxoSmithKline’s R&D space in King of Prussia, Pennsylvania it acquired the previous year for about $50 million with the goal of turning the space into "co-working" ecosystem for healthcare, life sciences and technology-enabled companies.